Use of a ventricular septal defect occluder for apical closure in transapical aortic valve replacement.
Détails
ID Serval
serval:BIB_07EDA7E358FB
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Etude de cas (case report): rapporte une observation et la commente brièvement.
Collection
Publications
Institution
Titre
Use of a ventricular septal defect occluder for apical closure in transapical aortic valve replacement.
Périodique
Innovations
ISSN
1559-0879 (Electronic)
ISSN-L
1556-9845
Statut éditorial
Publié
Date de publication
2015
Peer-reviewed
Oui
Volume
10
Numéro
1
Pages
68-70
Langue
anglais
Résumé
During transapical transcatheter aortic valve replacement (TA-TAVR), the apical closure remains a challenge for the surgeon, having the risk for ventricular tear and massive bleeding. Apical closure devices are already under clinical evaluation, but only a few can lead to a full percutaneous TA-TAVR. We describe the successful use of a 9-mm myocardial occluder (ventricular septal defect occluder) that was used to seal the apex after a standard TA-TAVR (using the Sapien XT 23-mm transcatheter valve and the Ascendra + delivery system). The placement of the nonmodified myocardial occluder was performed through the Ascendra + delivery system, with a very small amount of blood loss and an acceptable sealing of the apical tear. This approach is feasible and represents a further step toward true-percutaneous transapical heart valve procedures. Modified apical occluders are under evaluation in animal models.
Pubmed
Création de la notice
26/05/2015 11:49
Dernière modification de la notice
20/08/2019 13:30